This has certainly been the year of acquisitions within the 3D printing space, at least when it comes to the two giants within the industry; 3D Systems and Stratasys. In what seems to be a tit-for-tat acquisition spree for both companies, Stratasys has just added another ‘tat’.
The company has just announced that they have agreed to terms to acquired GrabCAD in an all cash deal. The deal for the Cambridge, MA company, founded in 2010, in which TechCrunch reports to be worth approximately $100 million, will close sometime by the end of this month.
GrabCAD is basically a file sharing service for CAD models, which allows designers and engineers to to work together on projects, ensuring that the most updated version of each model is seen by all members of a design team. Currently, with over one million engineers using the service, and over 520,000 free downloadable CAD models, the service will put Stratasys instantly atop the collaborative CAD model market.
“The addition of GrabCAD provides Stratasys with a leading cloud-based collaboration platform for engineering teams to manage, share and view CAD files,” said David Reis, Stratasys Chief Executive Officer. “By increasing the collaboration and accessibility of 3D CAD files, we believe we can further accelerate the adoption of 3D printing solutions and Stratasys’ product offerings. Together with GrabCAD, we believe that we will accelerate innovation and provide increased value to a growing universe of customers seeking to utilize 3D printing solutions. We also welcome GrabCAD’s active and important community to the Stratasys family. The potential within our 3D ecosystem is very exciting.”
The acquisition, which is likely a way for Stratasys to both take control of a growing CAD modeling marketplace, as well as acquire the immense talents behind the company, will certainly allow for GrabCad to see additional growth now that they are a unit within the Stratasys Global Products and Technology Group.
As the market gets more competitive, and a land grab ensues, talent as well as strong business practices will continue to be key acquisition targets. Bre Pettis, the Co-founder of MakerBot, which was later acquired by Stratasys, just tweeted, “Just gotta say again how excited I am about the genius talent at GrabCAD.”
“GrabCAD was founded to bring the world’s engineers together and help them collaborate to bring better products to market faster,” said Hardi Meybaum, Chief Executive Officer of GrabCAD. “By joining forces with Stratasys, a global leader in 3D printing and additive manufacturing, we believe we can extend the reach of one of the most exciting and innovative design collaboration technologies available. With its broad and growing customer base and worldwide presence, Stratasys can provide more customers around the world with exciting new solutions to meet their design needs.”
Hardi Meybaum, the Co-founder and CEO of GrabCAD, will continue to lead GradCAD as a subsidiary of Stratasys. Let’s hear your thoughts on this acquisition in the Stratasys/GrabCAD forum thread on 3DPB.com.
You May Also Like
3D Printing News Briefs, October 9, 2021: Automation, Bioprinting, & More
We’re starting with new materials in today’s 3D Printing News Briefs, then moving on to automation, bioprinting, and business. B9Creations introduced new resins for 3D printed molds and production parts,...
Bioprinted Brain Cells Made Possible with Laser-Based 3D Printing
Scientists from the Université de Montréal have published a study detailing the ability to bioprint adult brain cells. Key to the research was a new laser-assisted technology that made it...
Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over
In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,...
Can Fluicell’s Bioprinted Tissue Help Treat Type 1 Diabetes?
As Swedish bioprinter manufacturer Fluicell prepares to enter the regenerative medicine market through its BioRej Advance program, it focuses on developing therapeutic products based on bioprinted transplantable microtissues targeting important...
View our broad assortment of in house and third party products.